Depomed (DEPO) Tops Q4 EPS by 12c
Tweet
Share
E-mail
Get Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Total other income (expense): -20.19M
Today's EPS Names:
FOMI, FLES, IMMR, More
Financial Fact:
Total other income (expense): -20.19M
Today's EPS Names:
FOMI, FLES, IMMR, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q4 EPS of $0.48, $0.12 better than the analyst estimate of $0.36. Revenue for the quarter came in at $123.9 million versus the consensus estimate of $123.28 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- JPMorgan Reiterates Overweight Rating on Adani Ports & Special Economic Zone (ADSEZ:IN)
- Evercore ISI Upgrades Saia Inc. (SAIA) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
